SCHEMBL3356863

SCHEMBL3356863

CNC(=O)Cn1ccc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.50
KRAS P01116 1/20 0.48
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
POLB P06746 1/20 0.44
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
NPC1 O15118 1/20 0.44
AR P10275 1/20 0.44
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13139566 0.85 HTR7 (0.53) HTR7KRASALDH1A1KDM4EHPGD
SCHEMBL3354019 0.84 HTR7 (0.50) HTR7KRASALDH1A1KDM4EHPGD
SCHEMBL23631701 0.84 KRAS (0.46) HTR7KRASALDH1A1KDM4EHPGD
SCHEMBL2873839 0.83 KMT2A (0.54) HTR7KRASPOLBNPC1AR
SCHEMBL2870320 0.83 KMT2A (0.54) HTR7KRASPOLBNPC1AR
SCHEMBL23631640 0.83 KDM4E (0.51) HTR7KRASALDH1A1KDM4EHPGD
SCHEMBL3356235 0.82 HTR7 (0.50) HTR7KRASALDH1A1NPC1AR
SCHEMBL3356633 0.82 HTR7 (0.50) HTR7KRASALDH1A1NPC1AR
SCHEMBL1122247 0.80 ALDH1A1 (0.52) HTR7ALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL3312100 0.79 HTR7 (0.57) HTR7ALDH1A1SMN1; SMN2NPC1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed